ZNRF3 and liver cancer: In summary, our results indicated that human liver cancer patients bearing ZNRF3 and/or RNF43 mutations present altered liver lipid metabolism, in agreement with our findings in the Rnf43/Znrf3 mutant mouse model, and identified ZNRF3 and/or RNF43 as potential prognostic biomarkers for liver cancer.